Apathy in Dementia Methylphenidate Trial 2

NCT02346201 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Apathy
Alzheimer's Disease

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

[object Object]